PWCT represents a novel functional biomarker of left atrial posterior wall remodeling, independent of structural changes, potentially identifying patients for targeted ablation.
Does PWCT identify LAPW remodeling to guide targeted ablation in patients with atrial fibrillation?
PWCT may serve as a novel functional biomarker for left atrial posterior wall remodeling to potentially guide personalized AF ablation.
Tasa de eventos absoluta: 0% vs 0%
PWCT may represent a novel functional biomarker of LAPW remodeling, independent of structural changes, potentially identifying patients who may benefit from targeted LAPW ablation. Further studies are needed to validate PWCT as a guide for personalized AF ablation.
Malaty et al. (Wed,) reported a other. PWCT represents a novel functional biomarker of left atrial posterior wall remodeling, independent of structural changes, potentially identifying patients for targeted ablation.